Journal Article Summary
The article discusses the troubling issue of topical formulations of itraconazole, particularly in India, where lax regulatory practices and unethical pharmaceutical companies have led to the marketing of potentially harmful drug combinations. The authors highlight the dangers posed by fixed drug combination (FDC) creams, which often include multiple active ingredients that can exacerbate skin conditions like chronic dermatophytosis (tinea). This topic is significant because the misuse of these formulations can lead to increased resistance to antifungal treatments, complicating patient care and worsening public health outcomes.
The study examines the current landscape of topical itraconazole products in India, focusing on the illegal manufacturing and marketing of these creams without proper safety and efficacy data. The authors note that many of these products are being promoted by untrained pharmacists and prescribed by general practitioners, leading to widespread self-medication among the public. Key findings indicate that the introduction of these formulations, particularly those containing itraconazole combined with potent corticosteroids and unnecessary antibacterial agents, poses a serious risk of developing resistance in fungal infections, which is already a growing concern in the country.
The article acknowledges several limitations, including the lack of published studies on the efficacy of topical itraconazole for skin infections and the questionable formulation practices currently in use. For patients, this raises important safety concerns, as the erratic use of these products can lead to severe side effects and ineffective treatment. Readers are encouraged to discuss any use of topical antifungal treatments with their healthcare professionals to ensure safe and appropriate care, especially in light of the ongoing issues surrounding the regulation and approval of such medications in India.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Verma Shyam Bhanushankar, Saraswat Abir, Rao P. Narsimha, Dogra Sunil. Topical Itraconazole Formulations: Unscrupulous Pharmaceutical Companies and Lax Indian Drug Regulators Endangering a Precious Drug. Indian Dermatology Online Journal 2020. DOI: 10.4103/idoj.IDOJ_659_20. PMID: 33235852. PMCID: PMC7678552.
Featured Pill Pals Product
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) --- Generic for Lotrimin AF Pack of 5 --- Major / Rugby --- Over The Counter
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) — Generic for Lotrimin AF Pack of 5 — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
